AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $49,349,000 | +15.9% | 5,250,023 | -5.7% | 0.00% | 0.0% |
| Q2 2020 | $42,568,000 | +21.1% | 5,564,538 | -2.2% | 0.00% | 0.0% |
| Q1 2020 | $35,164,000 | -48.1% | 5,689,864 | +2.1% | 0.00% | -33.3% |
| Q4 2019 | $67,803,000 | +9.1% | 5,571,440 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $62,147,000 | +17.3% | 5,380,548 | +1.5% | 0.00% | +50.0% |
| Q2 2019 | $52,971,000 | -22.1% | 5,302,612 | +0.4% | 0.00% | -33.3% |
| Q1 2019 | $67,997,000 | -18.2% | 5,279,307 | -3.5% | 0.00% | -25.0% |
| Q4 2018 | $83,142,000 | -22.3% | 5,473,471 | +2.4% | 0.00% | -20.0% |
| Q3 2018 | $106,957,000 | +4.7% | 5,347,780 | +2.1% | 0.01% | 0.0% |
| Q2 2018 | $102,120,000 | -2.3% | 5,237,009 | +0.9% | 0.01% | 0.0% |
| Q1 2018 | $104,557,000 | +43.8% | 5,188,899 | -5.5% | 0.01% | +66.7% |
| Q4 2017 | $72,723,000 | -25.5% | 5,488,539 | +3.8% | 0.00% | -40.0% |
| Q3 2017 | $97,570,000 | +3.0% | 5,288,334 | +2.7% | 0.01% | 0.0% |
| Q2 2017 | $94,768,000 | -15.9% | 5,150,354 | +3.1% | 0.01% | -16.7% |
| Q1 2017 | $112,647,000 | +43902.7% | 4,995,412 | +67790.9% | 0.01% | – |
| Q4 2016 | $256,000 | +40.7% | 7,358 | -0.9% | 0.00% | – |
| Q3 2016 | $182,000 | +9.0% | 7,428 | +6.2% | 0.00% | – |
| Q2 2016 | $167,000 | +65.3% | 6,996 | +62.7% | 0.00% | – |
| Q1 2016 | $101,000 | +405.0% | 4,299 | +528.5% | 0.00% | – |
| Q4 2015 | $20,000 | -28.6% | 684 | 0.0% | 0.00% | – |
| Q3 2015 | $28,000 | -40.4% | 684 | 0.0% | 0.00% | – |
| Q2 2015 | $47,000 | +23.7% | 684 | 0.0% | 0.00% | – |
| Q1 2015 | $38,000 | +31.0% | 684 | 0.0% | 0.00% | – |
| Q4 2014 | $29,000 | +26.1% | 684 | -5.3% | 0.00% | – |
| Q3 2014 | $23,000 | +53.3% | 722 | 0.0% | 0.00% | – |
| Q2 2014 | $15,000 | +7.1% | 722 | -0.4% | 0.00% | – |
| Q1 2014 | $14,000 | -17.6% | 725 | 0.0% | 0.00% | – |
| Q4 2013 | $17,000 | +6.2% | 725 | 0.0% | 0.00% | – |
| Q3 2013 | $16,000 | 0.0% | 725 | 0.0% | 0.00% | – |
| Q2 2013 | $16,000 | – | 725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |